Bergabunglah dengan Buletin Kami
Bergabunglah dengan daftar pelanggan kami untuk mendapatkan artikel terkini, update dan penawaran khusus langsung di kotak masuk Anda
The common cold comes for us all—often more than once a year. And there is no wa...
What will it take to build a stronger, more resilient U.S. life sciences industr...
John Crowley emphasized industry modernization and solving "man-made problems" t...
UCI Health has launched the world’s first human clinical trial using embryonic s...
The common cold comes for us all—often more than once a year. And there is no wa...
This GEN Spotlight on RNA Therapeutics brings you three interlinked sessions tha...
The physical AI system, named AI Experimentalist, translates research goals from...
The WHO has selected Ireland’s NIBRT as its European hub for engineering educati...
As more than 100 clinical trials test human pluripotent stem cell-derived therap...
Manufacturing weight loss drugs at high volume at lower cost with less wastage c...
A new feeder cell line multiplies NK cells by more than 100,000-fold in one mont...
Biotechnology’s first 50 years were built on a uniquely American formula: world-...
BIOCOM California quantified the economic impact of the Golden State’s life scie...
A hospitalist-led procedure service in a community-hospital setting delivered pr...
Eli Lilly has agreed to acquire Sangamo’s capsid delivery platform, zinc finger ...
“Last year was a very business-as-usual year,” said Daniel Chancellor, VP of Tho...
